End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14,900 KRW | +1.29% | +4.93% | +7.89% |
2023 | Taekyung Chemical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2022 | South Korea's LG Chem plans to build hydrogen plant to cut carbon emissions | RE |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.89% | 125M | - | ||
+5.31% | 208B | A- | ||
+21.82% | 12.81B | B | ||
+68.03% | 9.62B | C+ | ||
-9.04% | 3.62B | D+ | ||
+16.35% | 3.29B | C- | ||
+15.47% | 3.17B | C+ | ||
-14.82% | 2.12B | - | ||
-11.34% | 1.84B | - | ||
+7.09% | 1.72B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- A006890 Stock
- Ratings Taekyung Chemical Co., Ltd.